NCT05305820

Brief Summary

People who are diagnosed with cancer of the colon/rectum/appendix/ovaries that spreads into the lining of the tummy and some ovarian cancers or people with pseudomyxoma peritonei can often undergo intensive treatment including major surgery where chemotherapy is given whilst the person is having surgery - also known by doctors as surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Fitness for this surgery can improve if people undertake a prehabilitation programme at the time they get their diagnosis. To date, little research has focused on how exercise and nutrition support before surgery can help these patients during recovery. The aim of this study is to explore the use of exercise and nutritional support pre-treatment to enhance physical and psychological outcomes for patients.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2022

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 15, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 31, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

September 1, 2022

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

March 21, 2024

Status Verified

March 1, 2024

Enrollment Period

1.8 years

First QC Date

February 15, 2022

Last Update Submit

March 20, 2024

Conditions

Keywords

Peritoneal Malignancy

Outcome Measures

Primary Outcomes (4)

  • Feasibility of Adherence to the Intervention

    Prehabilitation fidelity in terms of the patient group adherence as measured by patient structured qualitative feedback and activity logs.

    2-6 weeks pre surgery, 6 weeks post-surgery

  • Feasibility of participant retention to the Intervention

    Prehabilitation fidelity in terms of the patient group retention as measured by patient screening and retention logs and monitoring of recruitment rates.

    2-6 weeks pre-surgery, 6 weeks post-surgery

  • Feasibility of intervention effectiveness

    Prehabilitation fidelity in terms of intervention effectiveness as measured by qualitative patient feedback at two timepoints. Monitoring of patient activity logs. Engagement with online and in-person exercise and nutritional intervention resources.

    2-6 weeks pre-surgery, 6 weeks post-surgery

  • Change in Cardiorespiratory Fitness

    Cardiorespiratory fitness using the 6-Minute Walk Test (6MWT) assessed at the pre-surgery time point. The 6MWT is performed with participants walking up and down a 20 m course marked by cones for 6 min under instruction to cover as much ground as possible. The number of laps completed is recorded. A standard set of instructions is used as per the European Respiratory Society guidelines. The 6MWT is a validated assessment of cardiorespiratory function in clinical populations.

    2-6 weeks pre-surgery, 6 weeks post-surgery

Secondary Outcomes (14)

  • Change in Strength - The Handgrip Test

    2-6 weeks pre-surgery, 6 weeks post-surgery

  • Change in Strength - The Stand to Sit Test

    2-6 weeks pre-surgery, 6 weeks post-surgery

  • Change in Activity - 3-day ActivPAL3 triaxial accelerometer

    2-6 weeks pre-surgery, 6 weeks post-surgery

  • Change in Psychological Stress

    2-6 weeks pre-surgery, 6 weeks post-surgery

  • Change in Psychological Stress- Impact of Events Scale

    2-6 weeks pre-surgery, 6 weeks post surgery

  • +9 more secondary outcomes

Other Outcomes (8)

  • Post-operative Morbidity- Post-surgery Morbidity Score

    Day 2 post

  • Post-operative Morbidity- The Clavien-Dindo classification

    Day 15 post

  • Post-Operative Morbidity- Comprehensive Complication Index

    Day 15 post

  • +5 more other outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

Exercise: The exercise training program was designed to improve physical fitness prior to surgery and for a 6-week period after surgery once deemed fit. Nutrition: The nutritional arm consists of nutritional intervention tailored to the outcome of the nutritional screening.Participants will be asked to take part in a dietary food recall system called Foodbook24, and based on their dietary needs will be supported in nutritional optimisation.

Behavioral: ExerciseBehavioral: Nutrition

Control

NO INTERVENTION

This group will receive standard oncological care and will receive no formal education of exercise or nutritional intervention.

Interventions

ExerciseBEHAVIORAL

Standard Exercise Program- Participants will be invited to take part in a structured home, supervised, or both, exercise program while undergoing treatment and for a six-week period when deemed fit post-surgery.

Also known as: Tailored Exercise Prehabilitation Program
Intervention
NutritionBEHAVIORAL

Participants will be screened for their nutritional health and tailored advice and education will be provided on an individualised basis. An online dietary recall tool will be used to track patients' dietary habits. This will occur from diagnosis until point of surgery and recommence for 6 weeks post-surgery once deemed physically fit.

Also known as: Nutritional Optimisation
Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age ≥18 years,
  • multidisciplinary team referral for CRS-HIPEC for colorectal/appendix/ovarian peritoneal disease or pseudomyxoma peritonei (+/- completed neoadjuvant cancer treatment)
  • WHO performance status ≤2.

You may not qualify if:

  • inability to provide informed consent,
  • impaired cognitive function with a reduced ability to either understand advice /instructions from or communicate with the research team,
  • declined surgery,
  • surgery in less than 2 weeks
  • pregnancy or breastfeeding,
  • inability to participate in the exercise training (unable to perform the 6 Minute Walk Test)
  • absolute contraindications to exercise testing, veganism.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Dublin City University

Dublin, Ireland

Location

Mater Misericordiae university hospital

Dublin, Ireland

Location

Royal College of Surgeons , Ireland

Dublin, Ireland

Location

MeSH Terms

Conditions

Ovarian NeoplasmsRectal NeoplasmsAppendiceal NeoplasmsColonic Neoplasms

Interventions

ExerciseNutritional Status

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Neoplasms, FemaleUrogenital NeoplasmsGenital DiseasesEndocrine System DiseasesGonadal DisordersColorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal DiseasesCecal NeoplasmsCecal DiseasesColonic Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaHealth StatusDemographyPopulation Characteristics

Study Officials

  • Jurgen Mulsow, Mr.

    Mater Misericordiae University Hospital

    PRINCIPAL INVESTIGATOR
  • Lisa Loughney, Dr.

    Royal College of Surgeons, Ireland

    PRINCIPAL INVESTIGATOR
  • Lorraine Boran, Dr.

    Dublin City University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
It will not be possible to be blinded to the to the allocation of participants due to their active involvement in the behavioural exercise and nutritional interventions during the study.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Parallel group randomised 1:1 controlled multi-centre trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Co-Investigator

Study Record Dates

First Submitted

February 15, 2022

First Posted

March 31, 2022

Study Start

September 1, 2022

Primary Completion

June 1, 2024

Study Completion

August 1, 2024

Last Updated

March 21, 2024

Record last verified: 2024-03

Locations